Literature DB >> 9072705

Successful use of hydroxyurea in beta-thalassemia major.

V R Arruda, C S Lima, S T Saad, F F Costa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9072705     DOI： 10.1056/NEJM199703273361318

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  Hematopoietic stem cell mobilization for gene therapy of adult patients with severe β-thalassemia: results of clinical trials using G-CSF or plerixafor in splenectomized and nonsplenectomized subjects.

Authors:  Evangelia Yannaki; Thalia Papayannopoulou; Erica Jonlin; Fani Zervou; Garyfalia Karponi; Angeliki Xagorari; Pamela Becker; Nikoleta Psatha; Ioannis Batsis; Panayotis Kaloyannidis; Varvara Tahynopoulou; Varnavas Constantinou; Asimina Bouinta; Konstantia Kotta; Aglaia Athanassiadou; Achilles Anagnostopoulos; Athanasios Fassas; George Stamatoyannopoulos
Journal:  Mol Ther       Date:  2011-09-27       Impact factor: 11.454

2.  Hydroxyurea (hydroxycarbamide) for transfusion-dependent β-thalassaemia.

Authors:  Saqib H Ansari; Zohra S Lassi; Salima M Khowaja; Syed Omair Adil; Tahir S Shamsi
Journal:  Cochrane Database Syst Rev       Date:  2019-03-16

Review 3.  Psychological therapies for thalassaemia.

Authors:  Kofi A Anie; Pia Massaglia
Journal:  Cochrane Database Syst Rev       Date:  2014-03-06

4.  Effects of Hydroxyurea on Skeletal Muscle Energetics and Function in a Mildly Anemic Mouse Model.

Authors:  Constance P Michel; Laurent A Messonnier; Benoit Giannesini; Benjamin Chatel; Christophe Vilmen; Yann Le Fur; David Bendahan
Journal:  Front Physiol       Date:  2022-06-15       Impact factor: 4.755

5.  The Xmn1 polymorphic site 5' to the (G)gamma gene and its correlation to the (G)gamma:(A)gamma ratio, age at first blood transfusion and clinical features in beta-thalassemia patients from Western Iran.

Authors:  Hooshang Nemati; Zohreh Rahimi; Gholamreza Bahrami
Journal:  Mol Biol Rep       Date:  2009-05-15       Impact factor: 2.316

Review 6.  Emerging Therapies.

Authors:  Amaliris Guerra; Khaled M Musallam; Ali T Taher; Stefano Rivella
Journal:  Hematol Oncol Clin North Am       Date:  2017-12-15       Impact factor: 3.722

7.  Hydroxyurea-inducible SAR1 gene acts through the Giα/JNK/Jun pathway to regulate γ-globin expression.

Authors:  Jianqiong Zhu; Kyung Chin; Wulin Aerbajinai; Chutima Kumkhaek; Hongzhen Li; Griffin P Rodgers
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

Review 8.  Treating hemoglobinopathies using gene-correction approaches: promises and challenges.

Authors:  Renee N Cottle; Ciaran M Lee; Gang Bao
Journal:  Hum Genet       Date:  2016-06-17       Impact factor: 4.132

9.  Thalassaemia intermedia: an update.

Authors:  Ali T Taher; Khaled M Musallam; Maria D Cappellini
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-08-29       Impact factor: 2.576
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.